GLP Watchdog

Compounding Pharmacy · Ocala, FL · Both

Wells Pharmacy Network Review

Wells Pharmacy Network runs a 503A compounding pharmacy in Ocala, Florida and an FDA-registered 503B outsourcing facility in Dyersburg, Tennessee. Its focus is hormone compounding, weight management and wellness.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

BothPCAB
Location: Ocala, FL
Website: Official site
States licensed: no list on file
7.9
★★★★☆7.9/10

Our own score · methodology

Telehealth Brands That Fill Through This Pharmacy

Each seller below names Wells Pharmacy Network as a pharmacy that compounds or fills its prescriptions, in its own site, terms or filings. We keep the page and the date we read it. Arrangements like these are commercial, and they get changed without announcement.

7.5/ 10

EverPrime

Best for: people who want labs and a video visit built into a compounded GLP-1 plan with one price at every dose

★★★★☆7.5/10

Editorial score · methodology

$169/moprepaid
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full EverPrime review →

GLP-1 Partners

None of these fill through Wells Pharmacy Network. They are compounded GLP-1 sellers we have an affiliate relationship with. Each carries the same score it would without one.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Cash-pay pricing · HSA/FSA accepted · every partner checked by our editors

9.1

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

Starting price: $59/mo + membership

Get started →Read review Collective →
9.3

Embody

A flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

Starting price: $79/mo

Get started →Read review Embody →
7.9

Luvo Health

Moving between compounded and brand without changing seller

Starting price: $99/mo

Get started →Read review Luvo Health →
8.7

Eden

Coverage in all 50 states, which most sellers will not confirm

Starting price: $99/mo

Get started →Read review Eden →

Accreditations and Standards

Sterile compounding in this country runs on one rulebook, General Chapter <797> of the United States Pharmacopeia[4]. Depending on what is being made, the finished preparation is then tested for sterility under USP <71>[5] and for bacterial endotoxins under USP <85>[6]. Every pharmacy on this page owes those standards already. Which regulator oversees the pharmacy depends on its route, set out in our explainer on 503A and 503B compounding pharmacies. What follows is what this one has added on top.

PCAB
An audit by the Pharmacy Compounding Accreditation Board, which ACHC operates. The pharmacy applies for it; nothing obliges it to. Assessors measure sterile and non-sterile compounding against national quality and safety standards, and a pharmacy that drops the accreditation still keeps its license.

What It Compounds

Whether any pharmacy may compound semaglutide or tirzepatide at all turns on where the reference product sits on the FDA Drug Shortage List. When a drug comes off that list the door closes, and it has closed before[7].

Semaglutide
Compounds semaglutide
Tirzepatide
Compounds tirzepatide

States Licensed

Wells Pharmacy Network publishes no state-by-state licensure list, so we cannot tell you whether it is licensed where you live. Put that question to your own state board of pharmacy before you fill anything here.

What Regulators Have on File

2014-11-10
FDA Warning Letter issued to Wells Pharmacy Network LLC citing serious deficiencies in sterile drug production practices. Source: Quackwatch archive of FDA letter.
2018-06-22
FDA Form 483 issued to Wells Pharmacy Network LLC, Ocala FL, following inspection. Observations included use of non-pharmaceutical-grade materials in drug preparation. Source: FDA.
2021-01-28
FDA Form 483 issued to the Wells 503B outsourcing facility in Dyersburg, Tennessee; FDA followed with an untitled letter on May 19, 2022.
2025-04-25
FDA Form 483 issued to the Wells 503B facility in Dyersburg, Tennessee; FDA followed with an untitled letter on October 14, 2025.
2026-04-09
FDA Form 483 issued to the Wells 503B facility in Dyersburg, Tennessee. FDA's outsourcing-facility register lists a response letter issued October 5, 2026 and an FMD-145 letter issued October 6, 2026.

Ratings Elsewhere

Google Reviews
3.7 / 5.0
Across 65 reviews

How GLP Watchdog Scored This Pharmacy

Accreditation held9/10
Standing with regulators5/10
States licensed0/10
GLP-1 compounding10/10
Years operating5/10

We research every score ourselves. The methodology page sets out how each part is weighted. To check any pharmacy yourself, follow the six public checks in our guide to verifying an online GLP-1 pharmacy, or run its name through the pharmacy legitimacy lookup.

Low confidence · Last verified · How we check provider data

Frequently Asked Questions

Here is what we can and cannot confirm. Wells Pharmacy Network operates as a Both compounding pharmacy out of Ocala, FL. PCAB accreditation sits on the record, which is an audit a compounding pharmacy volunteers for rather than one it owes anyone. Our records carry 5 documented regulatory action(s), listed further down this page.
Wells Pharmacy Network works out of Ocala, FL. We have not recorded its state license list, which is not the same as it holding none — confirm shipping to your state with the pharmacy or your state board.
Alongside its other compounded preparations, Wells Pharmacy Network makes compounded semaglutide and compounded tirzepatide. Being a Both pharmacy, it runs two arms: a patient-specific 503A side, and an FDA-registered 503B outsourcing facility. FDA says outsourcing facilities may not compound semaglutide or tirzepatide from bulk now that both shortages are over, so patient-specific GLP-1 orders should come from the 503A side.
Two things separate them: who inspects, and how much may be made at once. A 503B outsourcing facility registers with the FDA itself, works to current Good Manufacturing Practices (cGMP), submits to FDA inspection, and may make compounded medication in batches with no named patient attached. A 503A pharmacy cannot do that. It fills a prescription written for one patient, answers mainly to its state board of pharmacy, and works to the USP <797> standard for sterile compounding. Neither route produces an FDA-approved drug.

Glossary

The words sellers use, defined. Tap any term.

Where to fill semaglutideBack to the register
Sources & methodology — as of November 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.